Titre : Prolapsus viscéral

Prolapsus viscéral : Questions médicales fréquentes

Termes MeSH sélectionnés :

Chlamydia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prolapsus viscéral : Questions médicales les plus fréquentes", "headline": "Prolapsus viscéral : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prolapsus viscéral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prolapsus viscéral" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Prolapsus d'organe pelvien", "url": "https://questionsmedicales.fr/mesh/D056887", "about": { "@type": "MedicalCondition", "name": "Prolapsus d'organe pelvien", "code": { "@type": "MedicalCode", "code": "D056887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.300.842.624" } } }, "about": { "@type": "MedicalCondition", "name": "Prolapsus viscéral", "alternateName": "Visceral Prolapse", "code": { "@type": "MedicalCode", "code": "D014782", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Matthew D Barber", "url": "https://questionsmedicales.fr/author/Matthew%20D%20Barber", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Hans Peter Dietz", "url": "https://questionsmedicales.fr/author/Hans%20Peter%20Dietz", "affiliation": { "@type": "Organization", "name": "University of Sydney, Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Shannon L Wallace", "url": "https://questionsmedicales.fr/author/Shannon%20L%20Wallace", "affiliation": { "@type": "Organization", "name": "Division of Urogynecology and Pelvic Floor Disorders, Department of Subspecialty Care for Women's Health, Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH. Electronic address: wallacs8@ccf.org." } }, { "@type": "Person", "name": "Eric R Sokol", "url": "https://questionsmedicales.fr/author/Eric%20R%20Sokol", "affiliation": { "@type": "Organization", "name": "Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "\"Candidatus Euplotechlamydia quinta,\" a novel chlamydia-like bacterium hosted by the ciliate Euplotes octocarinatus (Ciliophora, Spirotrichea).", "datePublished": "2022-09-11", "url": "https://questionsmedicales.fr/article/36039907", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jeu.12945" } }, { "@type": "ScholarlyArticle", "name": "A Member of an Ancient Family of Bacterial Amino Acids Transporters Contributes to Chlamydia Nutritional Virulence and Immune Evasion.", "datePublished": "2023-02-27", "url": "https://questionsmedicales.fr/article/36847502", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/iai.00483-22" } }, { "@type": "ScholarlyArticle", "name": "Trends in Follow-up Testing Among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration, 2013 to 2019.", "datePublished": "2023-01-11", "url": "https://questionsmedicales.fr/article/36649595", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OLQ.0000000000001765" } }, { "@type": "ScholarlyArticle", "name": "Estimating Chlamydia and Gonorrhea Burden Among US Army Soldiers From Military Health System Data: Mind the Gap.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35948284", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OLQ.0000000000001693" } }, { "@type": "ScholarlyArticle", "name": "The impact of antibiotic treatment for syphilis, chlamydia, and gonorrhoea during pregnancy on birth outcomes: A systematic review and meta-analysis.", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37325885", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7189/jogh.13.04058" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "États anatomopathologiques", "item": "https://questionsmedicales.fr/mesh/D020763" }, { "@type": "ListItem", "position": 4, "name": "Prolapsus", "item": "https://questionsmedicales.fr/mesh/D011391" }, { "@type": "ListItem", "position": 5, "name": "Prolapsus d'organe pelvien", "item": "https://questionsmedicales.fr/mesh/D056887" }, { "@type": "ListItem", "position": 6, "name": "Prolapsus viscéral", "item": "https://questionsmedicales.fr/mesh/D014782" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prolapsus viscéral - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prolapsus viscéral", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prolapsus viscéral", "description": "Comment diagnostique-t-on un prolapsus viscéral ?\nQuels tests sont utilisés pour évaluer un prolapsus ?\nQuels signes cliniques indiquent un prolapsus ?\nLe prolapsus peut-il être confondu avec d'autres conditions ?\nQuelle est l'importance de l'examen physique ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prolapsus viscéral", "description": "Quels sont les symptômes courants du prolapsus ?\nLe prolapsus peut-il causer des problèmes urinaires ?\nY a-t-il des symptômes digestifs associés ?\nComment le prolapsus affecte-t-il la sexualité ?\nLes symptômes varient-ils selon le type de prolapsus ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prolapsus viscéral", "description": "Comment prévenir le prolapsus viscéral ?\nLe tabagisme influence-t-il le prolapsus ?\nLes grossesses multiples augmentent-elles le risque ?\nL'âge joue-t-il un rôle dans le prolapsus ?\nLes activités physiques peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prolapsus viscéral", "description": "Quels traitements sont disponibles pour le prolapsus ?\nQuand la chirurgie est-elle recommandée ?\nLes pessaires sont-ils efficaces ?\nQuels exercices aident à traiter le prolapsus ?\nY a-t-il des traitements médicaux non chirurgicaux ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prolapsus viscéral", "description": "Quelles complications peuvent survenir avec un prolapsus ?\nLe prolapsus peut-il entraîner des problèmes psychologiques ?\nY a-t-il un risque de récidive après traitement ?\nComment les infections sont-elles liées au prolapsus ?\nLe prolapsus peut-il affecter la fonction intestinale ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prolapsus viscéral", "description": "Quels sont les principaux facteurs de risque du prolapsus ?\nLe mode de vie influence-t-il le prolapsus ?\nLes antécédents chirurgicaux sont-ils un facteur ?\nLes troubles du collagène sont-ils liés au prolapsus ?\nLe stress physique a-t-il un impact ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Chlamydia&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un prolapsus viscéral ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par examen clinique et imageries comme l'échographie ou l'IRM." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer un prolapsus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'examen pelvien et des études urodynamiques peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un prolapsus ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une sensation de pesanteur ou des douleurs pelviennes peuvent indiquer un prolapsus." } }, { "@type": "Question", "name": "Le prolapsus peut-il être confondu avec d'autres conditions ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec des infections ou des tumeurs pelviennes." } }, { "@type": "Question", "name": "Quelle est l'importance de l'examen physique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'examen physique est crucial pour évaluer la gravité et le type de prolapsus." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du prolapsus ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur pelvienne, incontinence et sensation de masse dans le vagin." } }, { "@type": "Question", "name": "Le prolapsus peut-il causer des problèmes urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des difficultés à uriner ou des fuites urinaires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes digestifs associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la constipation ou des difficultés à déféquer peuvent survenir." } }, { "@type": "Question", "name": "Comment le prolapsus affecte-t-il la sexualité ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut causer des douleurs pendant les rapports sexuels et une diminution du désir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de prolapsus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'un prolapsus vaginal, rectal ou utérin." } }, { "@type": "Question", "name": "Comment prévenir le prolapsus viscéral ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un poids santé, faire des exercices pelviens et éviter de soulever des charges lourdes." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le prolapsus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affaiblir les tissus et augmenter le risque de prolapsus." } }, { "@type": "Question", "name": "Les grossesses multiples augmentent-elles le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les grossesses multiples peuvent affaiblir les muscles pelviens et favoriser le prolapsus." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le prolapsus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de prolapsus augmente avec l'âge en raison de la perte de tonus musculaire." } }, { "@type": "Question", "name": "Les activités physiques peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines activités comme le yoga peuvent renforcer le plancher pelvien et prévenir le prolapsus." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le prolapsus ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des exercices de renforcement, des pessaires et la chirurgie." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est recommandée lorsque les symptômes sont sévères et ne répondent pas aux autres traitements." } }, { "@type": "Question", "name": "Les pessaires sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les pessaires peuvent soutenir les organes et soulager les symptômes sans chirurgie." } }, { "@type": "Question", "name": "Quels exercices aident à traiter le prolapsus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les exercices de Kegel renforcent les muscles pelviens et peuvent aider à réduire les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements médicaux non chirurgicaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements comme la physiothérapie pelvienne peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un prolapsus ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'incontinence, des infections urinaires et des douleurs chroniques." } }, { "@type": "Question", "name": "Le prolapsus peut-il entraîner des problèmes psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut causer de l'anxiété, de la dépression et affecter la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive après traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le prolapsus peut récidiver même après un traitement chirurgical ou non chirurgical." } }, { "@type": "Question", "name": "Comment les infections sont-elles liées au prolapsus ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les prolapsus peuvent augmenter le risque d'infections urinaires et vaginales." } }, { "@type": "Question", "name": "Le prolapsus peut-il affecter la fonction intestinale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des problèmes de constipation et de défécation difficile." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du prolapsus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'accouchement, l'obésité, le vieillissement et les antécédents familiaux." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le prolapsus ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et le surpoids augmentent le risque de prolapsus." } }, { "@type": "Question", "name": "Les antécédents chirurgicaux sont-ils un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions chirurgicales pelviennes antérieures peuvent augmenter le risque de prolapsus." } }, { "@type": "Question", "name": "Les troubles du collagène sont-ils liés au prolapsus ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles du collagène peuvent affaiblir les tissus de soutien et favoriser le prolapsus." } }, { "@type": "Question", "name": "Le stress physique a-t-il un impact ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des efforts répétés ou un stress physique excessif peuvent contribuer au prolapsus." } } ] } ] }

Sources (380 au total)

Trends in Follow-up Testing Among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration, 2013 to 2019.

The Centers for Disease Control and Prevention (CDC) recommends testing patients with chlamydia (CT)/gonorrhea (GC) for other sexually transmitted infections (STIs) and repeating CT/GC testing 3 to 12... Molecular laboratory testing for CT/GC during January 1, 2013-December 31, 2020 was retrieved from Veterans Health Administration data sources. Patients were evaluated for syphilis, HIV, and repeat CT... A total of 41,630 of 1,005,761 CT (4.1%) and 17,649 of 1,013,198 GC (1.7%) results were positive. Median ages of positive CT/GC patients were 29 and 36 years, respectively. Repeat testing rates for CT... Nearly two-thirds of patients did not receive recommended repeat testing, and nearly one-third were not tested for HIV/syphilis. Veterans Health Administration providers may benefit from additional ed...

Estimating Chlamydia and Gonorrhea Burden Among US Army Soldiers From Military Health System Data: Mind the Gap.

Reporting systems are commonly used for chlamydia and gonorrhea surveillance and community burden assessments. Estimates are conservative given high proportions of asymptomatic cases and underreportin... Confirmed chlamydia and gonorrhea cases reported among active component soldiers were merged with laboratory and medical encounter records indicative of infection to identify incident cases during 201... Approximately 83% and 76% of respective chlamydia and gonorrhea cases were identified through reporting, compared with 87% and 67% through laboratory records, and 58% for both through medical encounte... Integration of laboratory and medical encounter data substantially improved burden estimation over reporting alone. Rates generated remain conservative because they only reflect documented cases. Incr...

The impact of antibiotic treatment for syphilis, chlamydia, and gonorrhoea during pregnancy on birth outcomes: A systematic review and meta-analysis.

Sexually transmissible infections are important causes of loss of health and lives in women and infants worldwide. This paper presents the methods and results of a systematic review that focuses on th... We searched PubMed, Embase, Cochrane Libraries, Global Health and Global Index Medicus for articles available until May 23rd, 2022. The search criteria focused on the impact of treatment for the three... Treatment for pregnant women with active syphilis reduced the risk of preterm birth by 52% (95% CI = 42%-61%; 11 043 participants, 15 studies; low quality); stillbirth by 79% (95% CI = 65%-88%; 14 667... Because few studies adjusted for potential confounding factors, the overall quality of evidence was considered low. However, given the consistent and large effects, we recommend updating the estimated...

Analyzing RNA-Seq data from Chlamydia with super broad transcriptomic activation: challenges, solutions, and implications for other systems.

RNA sequencing (RNA-Seq) offers profound insights into the complex transcriptomes of diverse biological systems. However, standard differential expression analysis pipelines based on DESeq2 and edgeR ... Standard analyses using unique chlamydial RNA-Seq reads alone identify nearly 300 upregulated and about 300 downregulated genes, significantly deviating from actual RNA-Seq read trends. By incorporati... This study highlights the limitations of standard RNA-Seq analysis tools in scenarios with extensive transcriptomic activation, such as in Chlamydia spp. during early infection. Our revised normalizat...

How Much Do Young Australians Know About Syphilis Compared With Chlamydia and Gonorrhea? Findings From an Online Survey.

There is increased heterosexual transmission of syphilis in Australia, an infection with severe outcomes. Australian policy emphasizes increasing sexually transmissible infection knowledge/awareness. ... Our online sexual health survey was open May 2 to June 21, 2022, to 16- to 29-year-olds in Australia. We asked participants if they were aware of syphilis, their personal risk perception, and perceive... Among 2018 participants (69.1% women, 48.9% heterosexual), 91.3% had heard of syphilis (vs. 97.2% for chlamydia and 93.3% for gonorrhea). Older (25-29 years; adjusted odds ratio [aOR], 2.4; 95% confid... Most young Australians are aware of syphilis, but few have comprehensive knowledge about the infection relative to chlamydia/gonorrhea. Considering increasing heterosexual transmission, syphilis healt...

Effect of COVID-19 pandemic restrictions on chlamydia and gonorrhoea notifications and testing in Queensland, Australia: an interrupted time series analysis.

To investigate trends in testing and notifications of chlamydia and gonorrhoea during the COVID-19 pandemic in Queensland, Australia.... Statewide disease notification and testing data between 1 January 2015 and 31 December 2021 were modelled using interrupted time series. A segmented regression model estimated the pre-pandemic trend a... There were 158 064 chlamydia and 33 404 gonorrhoea notifications and 2 107 057 combined chlamydia and gonorrhoea tests across the 72-month study period. All three studied outcomes were increasing prio... There is a difference between the immediate and sustained impact of the COVID-19 pandemic on reported chlamydia and gonorrhoea notifications and testing in Queensland, Australia. This prompts consider...

Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000-2019: A Mathematical Modeling Analysis.

Chlamydia remains a significant public health problem that contributes to adverse reproductive health outcomes. In the United States, sexually active women 24 years and younger are recommended to rece... We conducted a cost-effectiveness analysis of chlamydia screening, using a published calibrated pair formation transmission model that estimated trends in chlamydia screening coverage in the United St... Screening and PN from 2000 to 2015 were estimated to have averted 1.3 million (95% uncertainty interval [UI] 490,000-2.3 million) cases of pelvic inflammatory disease, 430,000 (95% UI, 160,000-760,000... Chlamydia screening and PN as implemented in the United States from 2000 through 2015 has substantially improved population health and provided good value for money when considering associated health ...

Sexual network characteristics and partnership types among men who have sex with men diagnosed with syphilis, gonorrhoea and/or chlamydia in Lima, Peru.

Sexual networks are known to structure sexually transmitted infection (STI) transmission among men who have sex with men (MSM). We sought to estimate the risks of STI diagnosis for various partnership... Our cross-sectional survey analysed data from 1376 MSM screened for a partner management intervention in Lima, Peru. Participants were tested for HIV, syphilis, gonorrhoea (NG) and chlamydia (CT) and ... 40.8% (n=561/1376) of participants were diagnosed with an STI (syphilis: 14.9%, NG/CT: 16.4%, coinfection: 9.5%). 47.9% of all participants were living with HIV and 8.9% were newly diagnosed. A greate... Sexual networks and partnership types of Peruvian MSM are associated with differential risks for STIs. Participants diagnosed with syphilis tended to meet single-encounter casual partners at SOPV, whi...